Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.

Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.

CDX1 is a transcription factor that plays a key role in intestinal development and differentiation. However, the downstream targets of CDX1 are less well defined than those of its close homologue, CDX2. We report here the identification of downstream targets of CDX1 using microarray gene-expression...

Bibliografiset tiedot
Päätekijät:	Chan, C, Wong, N, Liu, Y, Bicknell, D, Turley, H, Hollins, L, Miller, C, Wilding, J, Bodmer, W
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2009

Samankaltaisia teoksia

The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody
Tekijä: Bayrak Reyhan, et al.
Julkaistu: (2012-01-01)

Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.
Tekijä: Wong, N, et al.
Julkaistu: (2004)

Human Homeobox TGIFLX Regulates CDX1, CDX2, and OCT1 Genes Expression in Colorectal Cancer Cell Lines
Tekijä: Soroosh Shahryarhesami, et al.
Julkaistu: (2022-04-01)

CDX1 is an important molecular mediator of Barrett's metaplasia.
Tekijä: Wong, N, et al.
Julkaistu: (2005)

Cytokeratin 20-positive hepatocellular carcinoma
Tekijä: G. Faa, et al.
Julkaistu: (2009-12-01)

Cytokeratin 20-positive hepatocellular carcinoma
Tekijä: D. Fanni, et al.
Julkaistu: (2009-12-01)

Cytokeratin 7 negative and cytokeratin 20 positive orbital metastatic breast carcinoma
Tekijä: Sabrina Bergeron, MSc, et al.
Julkaistu: (2018-06-01)

Immunohistochemical Studies of Cytokeratins and Differentiation Markers in Bovine Ocular Squamous Cell Carcinoma
Tekijä: Helena Vala, et al.
Julkaistu: (2020-05-01)

p53 and cytokeratin 20 immune marker expression as dual marker in papillary lesions of urinary bladder
Tekijä: Anita P. Javalgi, et al.
Julkaistu: (2024-04-01)

Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
Tekijä: Jaudah Al-Maghrabi, et al.
Julkaistu: (2018-01-01)

Importance of cytokeratin-20 expression in papillary urothelial neoplasia
Tekijä: İbrahim Karabulut, et al.
Julkaistu: (2020-12-01)

Cdx1 and Cdx2 exhibit transcriptional specificity in the intestine.
Tekijä: Stephanie Grainger, et al.
Julkaistu: (2013-01-01)

Tumor budding in colorectal adenocarcinoma using cytokeratin 20 immunostaining
Tekijä: Chaitra N, et al.
Julkaistu: (2023-12-01)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers.
Tekijä: Woodford-Richens, K, et al.
Julkaistu: (2001)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers
Tekijä: Woodford-Richens, K, et al.
Julkaistu: (2001)

Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer.
Tekijä: Chung-Chieh Wang, et al.
Julkaistu: (2019-01-01)

Significance of Tumour Budding with Case Series Cytokeratin 20 Immunostaining as a Histopathological Prognostic Marker in Colorectal Adenocarcinoma
Tekijä: Munireddy Swathi, et al.
Julkaistu: (2019-01-01)

Combined immunohistochemistry of β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
Tekijä: Tokumoto Noriaki, et al.
Julkaistu: (2006-02-01)

Immunohistochemical Expression of CDX2 in Gastroesophageal Junction Biopsies: An Emerging Marker for Early Intestinal Differentiation of Barrett’s Metaplasia
Tekijä: Twisha Adhikari, et al.
Julkaistu: (2022-04-01)

CDX2 Expression in ovarian teratomatous cells with intestinal differentiation
Tekijä: M. Mora, et al.
Julkaistu: (2006-01-01)

Imaging features of mucinous carcinoma arising from mature teratoma showing cytokeratin 7+ and cytokeratin 20+ expression profile: A case report
Tekijä: Natsuko Atsukawa, MD, et al.
Julkaistu: (2024-04-01)

The role of SATB2, CDX2, CK7 and CK20 in differentiating primary versus metastatic ovarian carcinoma
Tekijä: Sana Tahir, et al.
Julkaistu: (2024-09-01)

The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.
Tekijä: Jain, R, et al.
Julkaistu: (2010)

Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer
Tekijä: Ying-Ying Du, et al.
Julkaistu: (2016-01-01)

Cytokeratins : advances in oncology /
Tekijä: Temple, Amy, editor
Julkaistu: (2015)

GenCDX / [cakera padat]
Tekijä: 397147 Klug, William S., et al.
Julkaistu: (2000)

Cytokeratin 17: An Adjunct Immunohistochemical Marker of Invasion in Squamous Neoplastic Skin Lesions
Tekijä: Cem Leblebici
Julkaistu: (2017-09-01)

Expression of cytokeratins 8 and 17 as a diagnostic marker of cervical intraepithelial neoplasia
Tekijä: Kalodimos George, et al.
Julkaistu: (2010-01-01)

Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
Tekijä: Mariko Urano-Takaoka, et al.
Julkaistu: (2022-01-01)

Selective activation of tumor growth-promoting Ca<sup>2+ </sup>channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2
Tekijä: Huber Christoph, et al.
Julkaistu: (2009-09-01)

The Importance of Cytokeratin 19 Expression in the Differentiation of Basal Cell Carcinoma and Trichoepithelioma
Tekijä: Recep Bedir, et al.
Julkaistu: (2015-01-01)

N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines
Tekijä: Stephanie Holst, et al.
Julkaistu: (2019-03-01)

Which urine marker test provides more diagnostic value in conjunction with standard cytology- ImmunoCyt/uCyt+ or Cytokeratin 20 expression
Tekijä: Soyuer Serdar, et al.
Julkaistu: (2009-06-01)

Differential expression level of cytokeratin 8 in cells of the bovine nucleus pulposus complicates the search for specific intervertebral disc cell markers.
Tekijä: Gilson, A, et al.
Julkaistu: (2010)

Clinicopathological Evaluation of Gall-Bladder Lesions in Cholecystectomy Specimens with Special Emphasis to Incidentally Detected Cases of Gall-Bladder Carcinoma Along with Immunohistochemical Study of Cytokeratin 7 and Cytokeratin 20
Tekijä: Kakoli Bora, et al.
Julkaistu: (2023-08-01)

Optimization of Cdx Transcription Factors Characteristics
Tekijä: Javanbakht T.
Julkaistu: (2023-08-01)

Anti-cytokeratin 7: a positive marker for epithelial dysplasia in flat bowel mucosa
Tekijä: Svjetlana Radović, et al.
Julkaistu: (2004-08-01)

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ
Tekijä: Fernando N. Aguiar, et al.
Julkaistu: (2013-05-01)

Cdx2 regulates immune cell infiltration in the intestine
Tekijä: Simon Chewchuk, et al.
Julkaistu: (2021-08-01)

Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
Tekijä: Dikshit Rajesh, et al.
Julkaistu: (2008-09-01)